XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Shares
ATM offerings
Common Shares
Registered direct offering
Common Shares
Additional Paid in Capital
ATM offerings
Additional Paid in Capital
Registered direct offering
Additional Paid in Capital
Accumulated Deficit
Noncontrolling Interest
ATM offerings
Registered direct offering
Total
Beginning Balance at Sep. 30, 2023     $ 14     $ 307,398,292 $ (302,447,147) $ (78,747)     $ 4,872,412
Beginning Balance (in shares) at Sep. 30, 2023     13,659                
Increase (Decrease) in Stockholders' Equity                      
Exercise of warrants, cashlessly (in shares)     2                
Stock based compensation expense           340,705         340,705
Common stock issued in ATM, net of offering costs       $ 45,566         $ 45,566    
Common stock issued in ATM, net of offering costs (In shares) 88                    
Deemed dividend - warrant repricing           77,757 (77,757)        
Net loss             (1,105,100) (25,181)     (1,130,281)
Ending Balance at Dec. 31, 2023     $ 14     307,862,320 (303,630,004) (103,928)     4,128,402
Ending Balance (in shares) at Dec. 31, 2023     13,749                
Beginning Balance at Sep. 30, 2023     $ 14     307,398,292 (302,447,147) (78,747)     4,872,412
Beginning Balance (in shares) at Sep. 30, 2023     13,659                
Increase (Decrease) in Stockholders' Equity                      
Net loss                     (5,624,064)
Ending Balance at Mar. 31, 2024     $ 17     308,207,643 (308,255,808) (127,237)     (175,385)
Ending Balance (in shares) at Mar. 31, 2024     17,348                
Beginning Balance at Dec. 31, 2023     $ 14     307,862,320 (303,630,004) (103,928)     4,128,402
Beginning Balance (in shares) at Dec. 31, 2023     13,749                
Increase (Decrease) in Stockholders' Equity                      
Stock based compensation expense           171,004         171,004
Common stock issued in ATM, net of offering costs   $ 3   $ 18,831 $ 158       $ 18,831 $ 161  
Common stock issued in ATM, net of offering costs (In shares) 88 3,228                  
Deemed dividend - warrant repricing           155,330 (155,330)        
Share issued upon restricted stock vesting (in shares)     283                
Net loss             (4,470,474) (23,309)     (4,493,783)
Ending Balance at Mar. 31, 2024     $ 17     308,207,643 (308,255,808) (127,237)     (175,385)
Ending Balance (in shares) at Mar. 31, 2024     17,348                
Beginning Balance at Sep. 30, 2024     $ 206     318,815,166 (309,672,755) (174,532)     $ 8,968,085
Beginning Balance (in shares) at Sep. 30, 2024     206,324               206,324
Increase (Decrease) in Stockholders' Equity                      
Exercise of warrants     $ 51     508,549         $ 508,600
Exercise of warrants (in shares)     51,323                
Exercise of warrants, cashlessly     $ 418     (418)          
Exercise of warrants, cashlessly (in shares)     418,419                
Stock based compensation expense           28,973         28,973
Common stock and pre-funded warrants issued in registered direct offering, net of offering costs     $ 406     5,712,294         5,712,700
Common stock and pre-funded warrants issued in registered direct offering, net of offering costs (in shares)     406,250                
Deemed dividend - warrant repricing           14,907,223 (14,907,223)        
Net loss             (2,639,412) (29,301)     (2,668,713)
Ending Balance at Dec. 31, 2024     $ 1,081     339,971,787 (327,219,390) (203,833)     12,549,645
Ending Balance (in shares) at Dec. 31, 2024     1,082,316                
Beginning Balance at Sep. 30, 2024     $ 206     318,815,166 (309,672,755) (174,532)     $ 8,968,085
Beginning Balance (in shares) at Sep. 30, 2024     206,324               206,324
Increase (Decrease) in Stockholders' Equity                      
Net loss                     $ (6,004,833)
Ending Balance at Mar. 31, 2025     $ 6,331     364,896,649 (354,442,994) (235,778)     $ 10,224,208
Ending Balance (in shares) at Mar. 31, 2025     6,331,410               6,331,410
Beginning Balance at Dec. 31, 2024     $ 1,081     339,971,787 (327,219,390) (203,833)     $ 12,549,645
Beginning Balance (in shares) at Dec. 31, 2024     1,082,316                
Increase (Decrease) in Stockholders' Equity                      
Exercise of warrants     $ 450     983,722         984,172
Exercise of warrants (in shares)     450,040                
Exercise of warrants, cashlessly     $ 4,723     (4,723)          
Exercise of warrants, cashlessly (in shares)     4,722,672                
Stock based compensation expense           26,511         26,511
Deemed dividend - warrant repricing           23,919,429 (23,919,429)        
Adjustment for reverse split     $ 77     (77)          
Adjustment for reverse split (in Shares)     76,382                
Net loss             (3,304,175) (31,945)     (3,336,120)
Ending Balance at Mar. 31, 2025     $ 6,331     $ 364,896,649 $ (354,442,994) $ (235,778)     $ 10,224,208
Ending Balance (in shares) at Mar. 31, 2025     6,331,410               6,331,410